FindTrial
Sign In

Risk analysis of central lymph node metastasis in papillary thyroid microcarcinoma: a retrospective cohort study

Risk analysis of central lymph node metastasis in papillary thyroid microcarcinoma: a retrospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900021569
Enrollment
Unknown
Registered
2019-02-27
Start date
2016-08-01
Completion date
Unknown
Last updated
2019-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Papillery Thyroid Microcarcinoma

Interventions

transfer group + non-transfer group:No

Sponsors

the First Affiliated Hospital of Jinzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 78 Years

Inclusion criteria

Inclusion criteria: A total of 254 PTMC patients who underwent total thyroidectomy or lobectomy plus pCLND in the First Affiliated Hospital of Jinzhou Medical University, China from August 2016 to October 2018 were enrolled in this study. All of the patients were confirmed by postoperative pathology after treatment and received surgery by the same surgeon.

Exclusion criteria

Exclusion criteria: No

Design outcomes

Primary

MeasureTime frame
central lynph mode metastasis;—

Countries

China

Contacts

Public ContactFang Chai

the First Affiliated Hospital of Jinzhou Medical University, Jinzhou 121000, P. R. China

chaifang730919@sina.com+86 18004969089

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026